Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Mar 2024 for Poseida Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Brent Warner: trading record in brief
Brent Warner (chief executive) discloses dealings in Poseida Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 1 March 2022 to 1 March 2024, the count stands at 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 4 March 2024: a share grant, in Poseida Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brent Warner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
80,743 shares0Common StockSEC:0000950170-24-024920:0
92,772 shares0Common StockSEC:0001209191-23-014910:0
307,881 shares0Common StockSEC:0001209191-22-014372:0
3 of 3 declarations
